A carregar...

Use and delivery of granulocyte colony–stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy—single-centre experience

BACKGROUND: Use of granulocyte colony-stimulating factor (g-csf) as primary prophylaxis against chemotherapy-induced neutropenia has significant cost implications. We examined use of g-csf for early-stage breast cancer patients at our centre. The study also examined the pattern of nurse-led patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhu, X., Bouganim, N., Vandermeer, L., Dent, S.F., Dranitsaris, G., Clemons, M.J.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3410835/
https://ncbi.nlm.nih.gov/pubmed/22876152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.948
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!